Skip to content

Pharmacokinetics of Ibuprofen Injection in Healthy Chinese Volunteers

Pharmacokinetics of Ibuprofen Injection in Healthy Chinese Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007063
Enrollment
Unknown
Registered
2015-09-15
Start date
2015-10-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fever,pain

Interventions

4:Ibuprofen Injection

Sponsors

Nanjing Hengdao Pharmaceutical Technology Co., LTD
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Healthy subject with age 8~45 years old; 2. BMI in range of 19~24kg/m2 [BMI=weight (kg)/height 2(m2)]; 3. Blood urine routine, liver kidney function, blood lipid, blood sugar are normal, urine pregnancy test negative in female subjects; 4. Subject should have a strong understof the object require of trial, sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic history for ingredients of investigator product, allergic disease, or allergic constitution; 2. History of tobacco, alcohol or drug abuse history; 3. Participated other clinical trial in the last 3 months; 4. Used any medicine in the last 4 weeks; 5. Any history of severe disease or medical history of digestive temcardiovascular tem, Liver, kidney; 6. HBV carrier; 7. Gestation period lactation period women; 8. Use of contraceptive drugs; 9. Blood donation or test blood donation in the last 3 month; 10. Patients with bleeding or bleeding tendency; 11. Patients with epilepsy history or central nervous disorder; 12. Other conditions that Subject cant complete the trial because of other reasons or unsuitable to participate in the trial considered by the researchers.

Design outcomes

Primary

MeasureTime frame
AUC;Cmax;Tmax;t1/2;AUCss;Css_min;

Contacts

Public ContactPing Feng
pfyq@yahoo.com+86 028-85423583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026